Boston AF Symposium 2014
Summary Reports for Patients
From my perspective, both the Boston AF Symposium 2014 and the field of A-Fib feel like they’ve reached new plateaus—onward and upward! Developments in the A-Fib field signaled or presaged a new level of service of A-Fib patients, even though much work still needs to be done to translate these new developments into better treatments.
From Dr. Jeremy Ruskin of Mass. General Hospital and Harvard Medical School:
“Steve Ryan’s summaries of the Boston A-Fib Symposium are terrific. Steve has the ability to synthesize and communicate accurately in clear and simple terms the essence of complex subjects. This is an exceptional skill and a great service to patients with atrial fibrillation.”
Note: My most recent reports are listed first. Just click on the title to jump to the full article.
REPORT TITLE | PRESENTER (S) | DATE POSTED | |
16. | A-Fib Producing Spots Outside the PVs | Dr. Vivek Reddy of Mount Sinai Hospital | September 25, 2014 |
15. | The New Era of Catheter Ablation Technology: Force Sensing Catheters | Dr. Moussa Mansour, Massachusetts General Hospital | September 11, 2014 |
14. | Catheter Ablation as Recommended First Choice | Dr Hugh Calkins, Johns Hopkins | September 9, 2014 |
13. | Catheter Ablation Complications: A 2014 In-depth Review and Comparison with AAD Therapy | Dr. David Keane of St. Vincent’s University Hospital, Dublin Ireland | July 11, 2014 |
12. | “Upstream Therapy” Concept: Alternative Therapies for A-Fib? | Dr. Eric Prystowsky of the Care Group in Indianapolis, IN | June 7, 2014 |
11. | Renal Sympathetic Denervation (RSDN) for A-Fib? | Dr. Vivek Reddy of Mount Sinai Medical Center, New York, NY | June 7, 2014 |
10. | Obesity Strong Predictor of A-Fib Risk and Recurrence | Dr. David Wilber of the Loyola University Medical Center, Chicago, IL | June 7, 2014 |
9. | ECGI vs. FIRM: Direct Comparison, Phase/Waveform Mapping | Dr. Phillip Cuculich of the Washington University School of Medicine in St. Louis, MO | May 14, 2014 |
8. | Bordeaux Approach to Ablation of Persistent A-Fib—ECGI & Circular Catheter | Dr. Pierre Jais of IHU LIRYC in Bordeaux, France | March 25, 2014 |
7. | How ECGI (Non-Invasive Electrocardiographic Imaging) Works | Dr. Michel Haissaguerre of the LIRYC Institute in Bordeaux, France | March 25, 2014 |
6. | Cellular Remodeling and Mapping of A-Fib | Dr. Sanjiv Narayan of the University of California, San Diego | March 24, 2014 |
5. | Fibrotic Atrial Cardiomyopathy (FACM)—Implications for Catheter Ablation of AF | Dr. Hans Kottkamp of the Heart Center Hirslanden, in Zürich, Switzerland | March 22, 2014 |
4. | High Fibrosis at Greater Risk of Stroke and Precludes Catheter Ablation: Lessons Learned from the DECAAF Trial | Dr. Nassir Marrouche of the Comprehensive Arrhythmia Research and Management Center (CARMA) at the University of Utah Health Sciences | March 16, 2014 |
3. | The Holy Grail: Preventing A-Fib by a GAl-3 Inhibitor | Dr. Jose Jalife, Center for Arrhythmia Research of the U. of Michigan | March 13, 2014 |
2. | Experiments in Atrial Remodeling in Sheep and the Transition From Paroxysmal to Persistent A-Fib | Dr. Jose Jalife, Center for Arrhythmia Research of the U. of Michigan | March 13, 2014 |
1. | Live via Satellite: Seven Ablation Cases from The Netherlands, France, Italy, Germany, Russia, Boston & Michigan, USA | Drs. Mark La Meir and Laurent Pison; Dr. Evgeny Pokushalov; Dr. Mélèze Hocini; Drs. Claudio Tondo, Gaetano Fassini and Antonio Bartorelli; Drs. Hocin, Michel Haissaguerre and Pierre Jais; Drs. Boris Schmidt and KR Julian Chun; Drs. Kevin Heist and Moussa Mansour | Jan 25, 2014 |
Return to: Boston AF Symposiums Summaries By Year